U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 27 - February 2, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 27 - February 2, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 01/28/2019
Location: Washington, DC
Subject: Advancing the Generation and Use of Real-World Evidence for Regulatory and Value-Based Payment Decision-Making
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Academia, government, industry, media, and other invited guests

Event Date: 01/29/2019
Location: Silver Spring, MD
Subject: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Workshop
FDA Participant/Group: Several FDA senior officials and staff members
Non FDA Participant/Group: Industry, government, media, patients, and other registered guests

Official Name: Patrizia Cavazzoni, M.D., (Acting), Deputy Director for Operation, CDER

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/31/2019
Location: College Park, MD
Subject: Produce Industry Meeting
FDA Participant/Group: SUSAN MAYNE; JENNIFER THOMAS; CATHERINE MCDERMOTT; KARI BARRETT; MICHAEL MAHOVIC; KARI IRVIN; JOANN GIVENS; JAMES GORNY; STEVEN MUSSER; JAN CARLSON; SAMIR ASSAR; DOUGLAS STEARN; DAVID GOLDMAN; JEFFREY FARRAR; WILLIAM CORRELL; ORVILLE HARRIS; REBECCA BUCKNER; MICHAEL ROGERS; LEANNE SKELTON; BARBARA CASSENS;
Non FDA Participant/Group: Several members of the romaine task force

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/31/2019
Location: Silver Spring, MD
Subject: Medical Devices: Collaborative Community Efforts
FDA Participant/Group: WILLIAM MAISEL; JOSHUA SILVERSTEIN;
Non FDA Participant/Group: Andrew Coats, Dave Francoeur, Larry Hertzler, Rick Staab, Scott Nuedelman, Scott Trevino, Shelia O'Donnell, Tim McGeath (Alliance for Quality Medical Device Servicing);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event